Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, originally known as BIIB037, is a complex endeavor to address emerging Alzheimer's disease. Created by Biogen, this molecule acts by removing amyloid plaques https://www.targetmol.com/compound/aducanumab